Georgia Prescription Drug Monitoring Program

Click to register for Georgia PDMP

Every Georgia prescriber is required to register with the state’s Prescription Drug Monitoring Program (PDMP) within 30 days of obtaining a DEA license.

The Georgia Composite Medical Board (GCMB) will take disciplinary action against prescribers who fail to register with the PDMP.

A prescriber may delegate their authority check the PDMP to two members of their medical staff. For a prescriber to delegate this authority to unlicensed or unregistered staff (i.e., an office manager or medical assistant), the staff member must register as a user of the PDMP.

A health care facility (e.g., hospital or ambulatory surgery center) may select two employees to serve as delegates per shift or rotation. At hospitals that provide emergency services, each prescriber may designate two individuals who are employed by that hospital per shift or rotation.

Any unauthorized use of PDMP data by a delegate can result in civil or criminal liability for the prescriber. Delegates may only use PDMP data for the purpose of providing medical care or to inform the prescriber of a patient’s potential use, misuse, abuse or underutilization of a prescribed medication.

Prescribers or their delegate must review the information from the PDMP when they prescribe a controlled substance that is listed in paragraph (1) or (2) of Code Section 16-13-26 or a benzodiazepine. This review is limited to the first time the prescriber issues a prescription for the given patient and at least every 90 days thereafter.

Exemptions from the requirement to check the PDMP database are as follows…

– Prescriptions for no more than a three-day supply of a covered substance and no more than 26 pills

– The patient is in a hospital or health care facility, including – but not limited to – a nursing home, an intermediate care home, a personal care home, or a hospice program that provides patient care and whereby the prescriptions are to be administered and used by a patient on the premises of the facility

– The patient has had outpatient surgery at a hospital or ambulatory surgical center and the prescription is for no more than a 10-day supply of a covered substance and no more than 40 pills

– The patient is terminally ill or under the supervised care of an outpatient hospice program

– The patient is receiving treatment for cancer

Prescribers or their delegate must make a notation in the patient’s medical record that the PDMP was checked and they must identify the individual who conducted the PDMP patient search. If the PDMP does not allow the prescriber/delegate to gain access to the patient’s information for any reason, the prescriber/delegate should note the time and date and the prescriber/delegate’s name in the patient’s medical record.

Prescribers may include PDMP prescription information in a patient’s electronic health or medical record.

If a prescriber fails to check the PDMP, they will be held administratively accountable to GCMB – but they will not be held civilly liable or criminally responsible.  

When prescribing an opiate, opioid, opioid analgesic, or opioid derivative, the prescriber must provide the patient with information on the drug’s addictive risks and the options that are available for safely disposing of any unused medications. This information may be provided in verbal or written form.  

A health care provider, coroner, or medical examiner must report all incidents of neonatal abstinence syndrome to the Georgia Department of Public Health (DPH), which will submit an annual report – including findings and recommendations on how to reduce the number of infants born with neonatal abstinence syndrome – to the president of the Georgia Senate, the speaker of the Georgia House of Representatives, and the chairs of the Georgia House and Senate Health and Human Services committees.

GCMB has “adopted Rule 360-15-.01(3), which requires physicians (not resident physicians) who maintain an active DEA license and prescribe controlled substances to complete at least three hours of AMA/AOA PRA Category 1 CME that is designed specifically to address controlled substance prescribing practices by their next renewal date. The completion of this requirement may count as three hours toward the physician’s CME license renewal requirement. Note, too, that any controlled substances prescribing guidelines coursework that has been taken since a physician’s license ‘last expired’ will count toward this requirement.”    

MAG members can contact Bethany Sherrer at bsherrer@mag.org or 678.303.9273 with questions related to the Georgia PDMP.

Click for MAG ‘Georgia PDMP Fact Sheet’